BRIEF published on 07/01/2026 at 09:27, 2 months 28 days ago Valerio Therapeutics Proposes to Acquire Etherna Immunotherapies Biotechnology Valerio Therapeutics Acquisition Deal RNA Medicines Etherna Immunotherapies
BRIEF published on 07/01/2026 at 09:27, 2 months 28 days ago Valerio Therapeutics propose d'acquérir Etherna Immunotherapies Biotechnologie Accord D'acquisition Valerio Thérapeutique Médicaments À Base D'ARN Immunothérapies Etherna
BRIEF published on 07/01/2026 at 09:27, 2 months 28 days ago Valerio Therapeutics prépare l'acquisition d'Etherna Immunotherapies Valerio Therapeutics Investissement Biotechnologie Acquisition Etherna Médicaments ARN Fusion Entreprises
BRIEF published on 07/01/2026 at 09:27, 2 months 28 days ago Valerio Therapeutics is preparing to acquire Etherna Immunotherapies Valerio Therapeutics Biotechnology Investment Etherna Acquisition RNA Drugs Mergers Of Companies
PRESS RELEASE published on 07/01/2026 at 09:22, 2 months 28 days ago Informations privilégiées / Autres communiqués Valerio Therapeutics annonce l'acquisition d'Etherna Immunotherapies, devenant ainsi un leader mondial des médicaments à base d'ARN ciblés. L'opération vise à combiner deux technologies pour le développement de nouveaux traitements Acquisition Innovation Biotechnologie Valerio Therapeutics Médicaments ARN Ciblés
PRESS RELEASE published on 07/01/2026 at 09:22, 2 months 28 days ago Inside Information / Other news releases Valerio Therapeutics announces binding offer to acquire Etherna Immunotherapies, creating global leader in targeted RNA medicines. Strategic move unlocked by leading investors Acquisition Valerio Therapeutics RNA Medicines Targeted Delivery Etherna Immunotherapies
BRIEF published on 06/16/2026 at 19:48, 3 months 13 days ago Valerio Therapeutics nomme un nouveau PDG et confirme les résolutions de son assemblée générale annuelle Biotechnologie Transition Du PDG Valerio Thérapeutique Gilles Besin Médicaments À Base D'ARN
BRIEF published on 06/16/2026 at 19:48, 3 months 13 days ago Valerio Therapeutics Appoints New CEO and Confirms AGM Resolutions Biotechnology CEO Transition Valerio Therapeutics Gilles Besin RNA Medicines
PRESS RELEASE published on 06/16/2026 at 19:43, 3 months 13 days ago Informations privilégiées / Autres communiqués Valerio Therapeutics nomme Gilles Besin au poste de Directeur Général et annonce les résultats de son Assemblée Générale Annuelle, marquant une nouvelle phase d'innovation dans les thérapies ciblées de précision Biotechnologie Assemblée Générale Directeur Général Valerio Therapeutics Gilles Besin
PRESS RELEASE published on 06/16/2026 at 19:43, 3 months 13 days ago Inside Information / Other news releases Valerio Therapeutics appoints Gilles Besin as CEO, approved all resolutions at annual general meeting. Besin brings deep RNA and targeted delivery expertise to drive innovation Annual General Meeting Valerio Therapeutics Gilles Besin RNA Medicines Targeted Delivery
Published on 09/29/2026 at 22:15, 7 minutes ago CANEX Closes Oversubscribed $9.5 Million Equity Financing
Published on 09/29/2026 at 22:00, 22 minutes ago Rocky Shore Closes Springdale Property Acquisition and Completes Initial Payments Under the Handcamp Property Option Agreement
Published on 09/29/2026 at 16:45, 5 hours 37 minutes ago Gold Terra Announces Visible Mineralization in Hole CMUP-005 in Early Sonic Drilling at the Con Mine Historical Tailings, Yellowknife, NWT
Published on 09/29/2026 at 15:00, 7 hours 22 minutes ago As Crisis Events Intensify, BlackBerry and the American Red Cross Renew Commitment to Secure and Trusted Emergency Communications
Published on 09/29/2026 at 21:30, 52 minutes ago Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility
Published on 09/29/2026 at 19:47, 2 hours 35 minutes ago EQS-Adhoc: Marley Spoon Group SE: MARLEY SPOON GROUP SE REPORTS H1 2026 RESULTS AND GUIDANCE FOR 2026
Published on 09/29/2026 at 19:15, 3 hours 7 minutes ago Pensão Amor: Discover Lisbon's Most Surprising Hotel
Published on 09/29/2026 at 19:14, 3 hours 8 minutes ago EQS-Adhoc: Fabasoft AG: Fabasoft AG resolves share buyback
Published on 09/29/2026 at 19:14, 3 hours 8 minutes ago EQS-Adhoc: Fabasoft AG: Fabasoft AG resolves share buyback
Published on 09/29/2026 at 17:40, 4 hours 42 minutes ago Infotel : Mise à disposition du rapport financier semestriel 2026.
Published on 09/29/2026 at 17:40, 4 hours 42 minutes ago LDC : Nombre total de droits de vote et d'actions composant le capital au 31.08.26.
Published on 09/29/2026 at 14:15, 8 hours 6 minutes ago 260929 BENETEAU Mise en oeuvre du programme de rachat d'actions
